The classical chromosome Philadelphia-negative myeloproliferative neoplasms (MPNs) are a group of disorders that share clinical, hematological, and histological features. Proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) are elevated in patients with MPN. The aim of this study was to verify the association between the polymorphisms of TNF gene (-308G/A and -238 G/A) in BCR-ABL-negative MPN in our population. Blood samples obtained from MPN patients were genotyped for the JAK2V617F mutation and both TNF polymorphisms using PCR-RFLP. Thirty three (26.8%) patients with polycythemia vera (PV), 35 (28.7%) essential thrombocythemia (ET), 22 (17.7%) primary myelofibrosis (PMF), and 33 (26.8%) with unclassifiable MPN (MPNu) were inc...
BACKGROUND: The detection of molecular and cytogenetic alterations is important for the diagnosis, p...
Objective/backgroundMyeloproliferative neoplasms (MPNs) are heterogeneous clonal bone marrow stem ce...
Background: Cytokines are key immune mediators in physiological and disease processes, whose increas...
The classical chromosome Philadelphia-negative myeloproliferative neoplasms (MPNs) are a group of di...
This study aimed to verify the association between the JAK2 46/1 haplotype (V617F positive) and some...
Introduction: This study aimed to verify the association between the JAK2 46/1 haplotype (V617F posi...
Myeloproliferative neoplasms (MPNs) result from the malignant transformation of a hematopoietic stem...
Chronic myeloproliferative neoplasms (MPNs) are a group of related conditions characterized by the o...
The identification of the JAK2V617F mutation in several distinct myeloproliferative neoplasms (MPNs)...
OBJECTIVE: The JAK2 46/1 haplotype has recently been described as a major contributing factor to the...
Background : Three subtypes of myeloproliferative neoplasms (MPNs): Polycythemia vera (PV), essentia...
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflam...
Myeloproliferative neoplasms (MPNs) are clonal disorders characterized by increased production of ma...
LNK is an adapter protein negatively regulating the JAK/STAT cell signaling pathway. In this study, ...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Background: The JAK2 V617F mutat...
BACKGROUND: The detection of molecular and cytogenetic alterations is important for the diagnosis, p...
Objective/backgroundMyeloproliferative neoplasms (MPNs) are heterogeneous clonal bone marrow stem ce...
Background: Cytokines are key immune mediators in physiological and disease processes, whose increas...
The classical chromosome Philadelphia-negative myeloproliferative neoplasms (MPNs) are a group of di...
This study aimed to verify the association between the JAK2 46/1 haplotype (V617F positive) and some...
Introduction: This study aimed to verify the association between the JAK2 46/1 haplotype (V617F posi...
Myeloproliferative neoplasms (MPNs) result from the malignant transformation of a hematopoietic stem...
Chronic myeloproliferative neoplasms (MPNs) are a group of related conditions characterized by the o...
The identification of the JAK2V617F mutation in several distinct myeloproliferative neoplasms (MPNs)...
OBJECTIVE: The JAK2 46/1 haplotype has recently been described as a major contributing factor to the...
Background : Three subtypes of myeloproliferative neoplasms (MPNs): Polycythemia vera (PV), essentia...
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflam...
Myeloproliferative neoplasms (MPNs) are clonal disorders characterized by increased production of ma...
LNK is an adapter protein negatively regulating the JAK/STAT cell signaling pathway. In this study, ...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Background: The JAK2 V617F mutat...
BACKGROUND: The detection of molecular and cytogenetic alterations is important for the diagnosis, p...
Objective/backgroundMyeloproliferative neoplasms (MPNs) are heterogeneous clonal bone marrow stem ce...
Background: Cytokines are key immune mediators in physiological and disease processes, whose increas...